{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:55:40Z","timestamp":1791237340807,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbrep.2026.102703","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:49:49Z","timestamp":1783187389000},"page":"102703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical pathological changes in prostate cancer patients after hormonal therapy: A single-center pilot study"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8582-7474","authenticated-orcid":false,"given":"Raghda W.","family":"Magar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona Refaat","family":"Sadeq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawsan","family":"El-Halawani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary S.","family":"Karras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbrep.2026.102703_bib1","first-page":"1","article-title":"Epidemiological analysis of prostatic cancer: incidence, prevalence, mortality, and disability-adjusted life years in the Middle East","volume":"10","author":"Ayyad","year":"2025","journal-title":"Asian Pacific J. Cancer Biol."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102703_bib2","first-page":"145","article-title":"Pattern of prostate cancer presentation among the Egyptian population","volume":"26","author":"Elabbady","year":"2014","journal-title":"J. Egypt. Natl. Cancer Inst."},{"key":"10.1016\/j.bbrep.2026.102703_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1019247","article-title":"Expression analysis of cytokines IL-5, IL-6, IL-8, IL-17 and VEGF in breast cancer patients","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102703_bib4","first-page":"422","article-title":"Fibrinogen and D-dimer levels in prostate cancer: prognostic implications","volume":"13","author":"\u00c7al\u0131\u015fkan","year":"2017","journal-title":"J. Cancer Res. Therapeut."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102703_bib5","article-title":"Diagnostic efficacy of systemic immune-inflammation biomarkers in benign prostatic hyperplasia using receiver operating characteristic and artificial neural network","volume":"13","author":"Ahmed","year":"2023","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bbrep.2026.102703_bib6","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1111\/j.1440-1746.2006.04736.x","article-title":"Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus","volume":"22","author":"Takeuchi","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.bbrep.2026.102703_bib7","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3390\/cancers14061367","article-title":"Inflammation and prostate cancer: a multidisciplinary approach to identifying opportunities for treatment and prevention","volume":"14","author":"Huang","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bbrep.2026.102703_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12876-025-04249-4","article-title":"Coagulation markers as independent predictors of colorectal cancer prognosis","volume":"25","author":"El-Sayed","year":"2025","journal-title":"BMC Gastroenterol."},{"issue":"8","key":"10.1016\/j.bbrep.2026.102703_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00262-024-03723-4","article-title":"Evaluation of the clinical application value of cytokine expression profiles in the differential diagnosis of prostate cancer","volume":"73","author":"Chen","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"issue":"9","key":"10.1016\/j.bbrep.2026.102703_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT\u2013PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrep.2026.102703_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s40001-023-01562-0","article-title":"The clinical association between coagulation indexes, platelet\u2010related parameters, and bone metastasis of newly diagnosed prostate cancer","volume":"28","author":"Yu","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.bbrep.2026.102703_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/11795549241263950","article-title":"Peripheral coagulation parameters and prostate cancer association: a retrospective study and Mendelian randomization","volume":"18","author":"Liu","year":"2024","journal-title":"Clin. Med. Insights Oncol."},{"key":"10.1016\/j.bbrep.2026.102703_bib13","article-title":"Coagulation markers as independent predictors of prostate cancer aggressiveness: a retrospective cohort study","volume":"13","author":"Feng","year":"2023","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.bbrep.2026.102703_bib14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri1703","article-title":"NF-\u03baB: linking inflammation and immunity to cancer development and progression","volume":"5","author":"Karin","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.bbrep.2026.102703_bib15","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.3390\/ijms25084171","article-title":"Regulation of molecular biomarkers associated with the progression of prostate cancer","volume":"25","author":"Martin-Caraballo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102703_bib16","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-22-0228","article-title":"The androgen-thyroid hormone crosstalk in prostate cancer and the clinical implications","volume":"12","author":"Torabinejad","year":"2023","journal-title":"Eur. Thyroid J."},{"key":"10.1016\/j.bbrep.2026.102703_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102556","article-title":"Uncertainties and controversies in axillary management of patients with breast cancer","volume":"117","author":"Weber","year":"2023","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.bbrep.2026.102703_bib18","article-title":"Biomarkers for prostate cancer detection and risk stratification","volume":"14","author":"Farha","year":"2022","journal-title":"Therapeutic Adv. Urol."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102703_bib19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/cancers17020290","article-title":"IL-1\u03b2 in neoplastic disease and the role of its tumor-derived form in the progression and treatment of metastatic prostate cancer","volume":"17","author":"Oyende","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.bbrep.2026.102703_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102992","article-title":"Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: a systematic review and meta-analysis","volume":"151","author":"Buonerba","year":"2020","journal-title":"Crit. Rev. Oncol.-Hematol."},{"issue":"12","key":"10.1016\/j.bbrep.2026.102703_bib21","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1158\/1541-7786.MCR-19-0540","article-title":"Prostate tumor cell-derived IL1\u03b2 induces an inflammatory phenotype in bone marrow adipocytes and reduces sensitivity to docetaxel via lipolysis-dependent mechanisms","volume":"17","author":"Herroon","year":"2019","journal-title":"Mol. Cancer Res. : MCR"},{"issue":"17","key":"10.1016\/j.bbrep.2026.102703_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202206889","article-title":"IL-1\u03b2 is an androgen-responsive target in macrophages for immunotherapy of prostate cancer","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci."},{"issue":"10","key":"10.1016\/j.bbrep.2026.102703_bib23","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.ejca.2013.02.026","article-title":"Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer","volume":"49","author":"Gannon","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbrep.2026.102703_bib24","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1186\/s12885-025-15091-y","article-title":"UHRF1 and NF-\u03baB signaling in prostate cancer progression insights from bioinformatics and experimental validation","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.bbrep.2026.102703_bib25","article-title":"Inflammatory markers in prostate cancer: potential roles in risk stratification and immune profiling","volume":"22","author":"Burzinskis","year":"2025","journal-title":"J. Immunot."},{"issue":"5","key":"10.1016\/j.bbrep.2026.102703_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2021.102251","article-title":"Metformin addition to androgen deprivation therapy effect on cancer prostate patients with type 2 diabetes","volume":"15","author":"Aboelnaga","year":"2021","journal-title":"Diabetes Metabol. Syndr."},{"key":"10.1016\/j.bbrep.2026.102703_bib27","doi-asserted-by":"crossref","unstructured":"A 10-Year Experience of Prostate Cancer Management in Two Centers in Assiut. SECI Oncol. J., 13(3), 198-208. https:\/\/doi:10.21608\/secioj.2025.447041.","DOI":"10.21608\/secioj.2025.447041"},{"issue":"4","key":"10.1016\/j.bbrep.2026.102703_bib28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.5173\/ceju.2014.04.art7","article-title":"Pattern of prostate cancer presentation among the Egyptian population: a study in a single tertiary care center","volume":"67","author":"Elabbady","year":"2014","journal-title":"Central Eur. J. Urol."},{"issue":"12","key":"10.1016\/j.bbrep.2026.102703_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278282","article-title":"The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: randomized trial","volume":"17","author":"Karkeet","year":"2022","journal-title":"PLoS One"}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826002633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826002633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:11:49Z","timestamp":1791234709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580826002633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"alternative-id":["S2405580826002633"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102703","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical pathological changes in prostate cancer patients after hormonal therapy: A single-center pilot study","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102703"}}